Welcome to our dedicated page for Celestica SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Celestica Inc. (CLS) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and financial performance. As an Ontario, Canada corporation with common shares listed on the New York Stock Exchange, Celestica submits reports under the Exchange Act, including current reports on Form 8-K that disclose material events.
Recent Form 8-K filings illustrate the types of information investors can expect. Celestica has reported quarterly financial results and related conference calls, furnished press releases as exhibits, and described its guidance and outlook for revenue, adjusted operating margin, adjusted EPS and non-GAAP free cash flow. Other 8-Ks detail corporate actions such as the launch and acceptance of a normal course issuer bid on the Toronto Stock Exchange to repurchase a portion of its public float, with information on the maximum number of shares, timing and cancellation of repurchased shares.
The company’s filings also cover governance and Board matters. Examples include the appointment of new independent directors, committee assignments, and planned transitions such as the resignation of a director and the designation of a new Audit Committee Chair. These disclosures provide transparency into Celestica’s oversight structure and the experience of its Board members.
Through this SEC filings page on Stock Titan, users can access Celestica’s regulatory documents as they are made available on EDGAR. AI-powered summaries help explain key points from lengthy filings, including financial results, segment commentary for Advanced Technology Solutions (ATS) and Connectivity & Cloud Solutions (CCS), capital allocation decisions like issuer bids, and changes in corporate governance. Investors can also review insider and executive-related disclosures contained in applicable forms to better understand leadership and oversight at Celestica.
Colpitts Christopher W. reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc director Christopher W. Colpitts received a grant of 276 director share units on March 31, 2026 at no cost. Each director share unit represents a contingent right to receive one common share or an equivalent cash amount when he ceases serving the company. Following this award, he directly holds 720 director share units tied to Celestica common shares.
Maletira Amar reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Amar Maletira received 300 Director Share Units as equity-based compensation. These units were granted at no cost and each represents a contingent right to receive one common share or an equivalent cash amount when he ceases serving Celestica as a director or other service provider.
Following this award, Maletira holds 1,292 Director Share Units linked to Celestica’s common shares, reflecting a routine, non-cash compensation grant rather than an open-market stock purchase or sale.
KOELLNER LAURETTE T reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc reported that director Laurette T. Koellner received a grant of 276 Director Share Units. These units were awarded at a price of $0.00 per unit as a form of equity compensation. Following this grant, Koellner holds a total of 446 Director Share Units. Each unit represents a contingent right to receive one common share of Celestica or an equivalent cash amount, at the company’s discretion, when she ceases serving as a director, consultant, or other service provider.
Celestica Inc. director Jill Kale reported routine equity compensation activity. On March 31, 2026, she exercised 287 Restricted Share Units (RSUs) into 287 Common Shares at $0.00 per share and had 17 Common Shares withheld at $257.27 per share to cover tax obligations.
She also received a new grant of 276 RSUs, each representing a contingent right to one Common Share or cash. Following these transactions, she directly holds 270 Common Shares and continues to hold RSUs granted on March 31, 2025 and March 31, 2026 that vest over three years.
Colpron Francoise reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Francoise Colpron received an equity award of 296 restricted share units on March 31, 2026. These RSUs were granted as compensation and give a contingent right to receive one common share or an equivalent cash amount for each unit.
According to the terms, one third of the 296 RSUs vests each year over three years on the anniversary of the grant date, so the award becomes fully vested over time rather than immediately.
Celestica Inc. director Robert Cascella reported routine equity compensation activity tied to restricted share units (RSUs). On March 31, 2026, he exercised 156 RSUs into the same number of common shares and received a new grant of 150 RSUs that vest in three annual installments starting on the grant anniversary. To cover tax obligations from the RSU vesting, 9 common shares were withheld at $257.27 per share, leaving him with 147 common shares directly held. After the transactions, he continues to hold 312 RSUs from a prior 468-unit grant in addition to the new 150-unit RSU award.
Ahuja Kulvinder reported acquisition or exercise transactions in this Form 4 filing.
Celestica Inc. director Kulvinder Ahuja received a grant of 138 Director Share Units. These units are a form of deferred compensation tied to the company’s common shares. After this award, Ahuja holds 633 Director Share Units in total.
Each Director Share Unit represents a right to receive one common share or an equivalent cash amount, at Celestica’s discretion, when the holder stops serving as a director, consultant or other service provider.
Celestica Inc. director Michael Max Wilson exercised equity awards and settled related taxes in shares. On March 31, 2026, he exercised restricted share units into 3,199 Common Shares and received an additional 398 Director Share Units as a grant.
To cover tax obligations from the RSU vesting, 1,536 Common Shares were withheld at a price of $257.09 per share, converted from Canadian dollars. After these transactions, he directly held 20,210 Common Shares, reflecting a modest net increase from compensation-related awards rather than open-market trading.
Celestica Inc. announced a planned board leadership transition and the appointment of a new independent director. Chair Michael Wilson will retire and not stand for re-election at the 2026 annual meeting, consistent with the company’s director retirement policy and with no disagreement over operations or governance.
Effective immediately before the 2026 annual meeting on May 19, 2026, President and CEO Rob Mionis will become Chair of the Board, and long-time director Laurette Koellner will serve as Lead Independent Director, providing independent oversight and leading executive sessions of independent directors. The board also appointed David Reeder as an independent director effective May 1, 2026 and named him to the Audit, Human Resources and Compensation, and Nominating and Corporate Governance Committees.
CLS notice: a proposed sale of 39,492 shares of Common Stock is listed as a compensatory payment dated 03/17/2026.
The excerpt also records a prior sale of 37 shares on 02/20/2026 for $10,703.29 by Luis Muller and identifies Kevin Reavey in the filer information.